Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Clinical Pharmacology and Therapeutics|November 24, 2001
Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2C Yao, K L Kunze, E D Kharasch, et al.
Biochemistry|April 12, 2000
Mechanism-based inactivation of cytochrome P450 3A4 by L-754,394L K Lightning, J P Jones, T Friedberg, et al.
Clinical Pharmacology and Therapeutics|May 1, 1994
Disposition of drugs in cystic fibrosis. VI. In vivo activity of cytochrome P450 isoforms involved in the metabolism of (R)-warfarin (including P450 3A4) is not enhanced in cystic fibrosisJ P Wang, J D Unadkat, S McNamara, et al.
Thrombosis Research|August 15, 1993
Thermal stability of low molecular weight urokinase during heat treatment. I. Effects of protein concentration, pH and ionic strengthW R Porter, H Staack, K Brandt, et al.
Clinical Pharmacology and Therapeutics|January 1, 1986
The warfarin-sulfinpyrazone interaction: stereochemical considerationsS Toon, L K Low, M Gibaldi, et al.
Clinical Pharmacology and Therapeutics|June 1, 1992
Mechanisms of the stereoselective interaction between miconazole and racemic warfarin in human subjectsR A O'Reilly, D A Goulart, K L Kunze, et al.
Chemical Research in Toxicology|May 5, 1998
Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6W Chen, L L Koenigs, S J Thompson, et al.
Pharmacogenetics|November 14, 1997
Genetic association between sensitivity to warfarin and expression of CYP2C9*3D J Steward, R L Haining, K R Henne, et al.
Molecular Pharmacology|August 1, 1987
Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implicationsL M Bornheim, M C Underwood, P Caldera, et al.
Archives of Biochemistry and Biophysics|November 1, 1987
Degradation of rat hepatic cytochrome P-450 heme by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine to irreversibly bound protein adductsM A Correia, C Decker, K Sugiyama, et al.
Pageof 11